Research output per year
Research output per year
Personal profile
About
Dr. Mody serves PCOM School of Pharmacy as an associate professor in the Department of Pharmaceutical Sciences. He is primarily involved in teaching biochemistry and medicinal chemistry of infectious disease and therapeutic courses.
Prior to joining PCOM School of Pharmacy, he served South University School of Pharmacy (September 2012 - October 2015) and Appalachian College of Pharmacy (August 2009 - August 2012).
Related documents
Education/Academic qualification
Post Doctoral Experience, University of Houston
2007 → 2009
PhD Chemistry, University of Houston
… → 2007
MSc Chemistry, Mumbai University
… → 2001
BSc Chemistry, Mumbai University
… → 1999
Disciplines
- Pharmacy and Pharmaceutical Sciences
-
To determine the compatibility of norepinephrine bitartrate with levofloxacin, acyclovir, ampicillin/sulbactam, azithromycin, cefepime, and isavuconazonium sulfate for Y- site administration
Khaki Najafabadi, I., Ethredge, H., Samuel, E., Singh, A., Mody, V. & Khaki, I., Dec 4 3027.Research output: Contribution to conference › Presentation
-
Aloin isoforms (A and B) selectively inhibits proteolytic and deubiquitinating activity of papain like protease (PLpro) of SARS-CoV-2 in vitro.
Lewis, D. S. M., Ho, J., Wills, S., Kawall, A., Sharma, A., Chavada, K., Ebert, M. C. C. J. C., Evoli, S., Singh, A., Rayalam, S., Mody, V. & Taval, S., Feb 9 2022, In: Scientific Reports. 12Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Barbaloin (Aloin-A) and isobarbaloin (Aloin-B) selectively inhibit activity of papain like protease (PLpro) of SARS-CoV-2 in vitro
Lewis, D. S., Chavada, K., Ho, J., Wills, S., Rayalam, S., Mody, V. & Taval, S., May 3 2022.Research output: Contribution to conference › Presentation
Open AccessFile -
Development of inhaled PLGA encapsulated Ivermectin for the treatment of SARS-CoV-2
Sood, S., Mody, V., Rayalam, S., Taval, S. & Jha, S., May 3 2022.Research output: Contribution to conference › Presentation
-
Identification of phytochemicals that inhibit the enzymatic activity of SARS-CoV-2 3-chymotrypsin like protease (3CLpro) in vitro.
Sharma, A., Kawall, A., Lewis, D., Chavada, K., Taval, S., Mody, V. & Rayalam, S., May 3 2022.Research output: Contribution to conference › Presentation
Open AccessFile